Page last updated: 2024-11-02

oxatomide and Muscular Dystrophy, Duchenne

oxatomide has been researched along with Muscular Dystrophy, Duchenne in 1 studies

oxatomide: structure; an anti-allergic & an anti-asthmatic
oxatomide : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one substituted by a 3-[4-(diphenylmethyl)piperazin-1-yl]propyl group at position 1. It is an anti-allergic drug.

Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buyse, GM1
Goemans, N1
Henricson, E1
Jara, A1
van den Hauwe, M1
Leshner, R1
Florence, JM1
Mayhew, JE1
Escolar, DM1

Trials

1 trial available for oxatomide and Muscular Dystrophy, Duchenne

ArticleYear
CINRG pilot trial of oxatomide in steroid-naïve Duchenne muscular dystrophy.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2007, Volume: 11, Issue:6

    Topics: Child; Child, Preschool; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Linear Models;

2007